Akèy › Kasinom in situ
Etid klinik pou Kasinom in situ ap rekrite nan Etazini
8 etid pou Kasinom in situ ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Austin, TX4 etid
- Little Rock, AR4 etid
- Houston, TX4 etid
- Boston, MA4 etid
- New York City, NY3 etid
- Cincinnati, OH3 etid
- Bakersfield, CA3 etid
- Portland, OR3 etid
- Philadelphia, PA3 etid
- Memphis, TN3 etid
- Los Angeles, CA3 etid
- Rochester, MN3 etid
- Pittsburgh, PA3 etid
- Nashville, TN3 etid
- Birmingham, AL3 etid
- Syracuse, NY3 etid
- Jacksonville, FL3 etid
- Myrtle Beach, SC3 etid
- St. Louis, MO3 etid
- Atlanta, GA3 etid
Pa eta
- Alabama3 etid
- Arizona4 etid
- Arkansas4 etid
- Colorado4 etid
- Florid4 etid
- Georgia3 etid
- Illinois3 etid
- Kalifòni5 etid
- Lwizyàn3 etid
- Massachusetts4 etid
- Minnesota3 etid
- Missouri4 etid
- New York4 etid
- Ohio4 etid
- Oregon3 etid
- Pennsylvania5 etid
- South Carolina4 etid
- Tennessee4 etid
- Texas5 etid
- Virginia4 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07480356InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT05463796LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
Ap rekriteFaz 2
Laj 18 a 99 · Tout sèks · Mizajou Apr 17, 2026 · NCT07322263EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Ap rekrite
Laj 20 a 89 · Fanm · Mizajou Feb 4, 2026 · NCT06115486Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.